RS53996B1 - COMPOSITIONS CONTAINING CORE-1 POSITIVE MICRO-ORGANISM AND THEIR APPLICATION FOR TREATMENT OR TUMOR PROPHYLAXIS - Google Patents

COMPOSITIONS CONTAINING CORE-1 POSITIVE MICRO-ORGANISM AND THEIR APPLICATION FOR TREATMENT OR TUMOR PROPHYLAXIS

Info

Publication number
RS53996B1
RS53996B1 RS20150240A RSP20150240A RS53996B1 RS 53996 B1 RS53996 B1 RS 53996B1 RS 20150240 A RS20150240 A RS 20150240A RS P20150240 A RSP20150240 A RS P20150240A RS 53996 B1 RS53996 B1 RS 53996B1
Authority
RS
Serbia
Prior art keywords
core
prophylaxis
tumors
compositions
treatment
Prior art date
Application number
RS20150240A
Other languages
English (en)
Serbian (sr)
Inventor
Steffen Goletz
Original Assignee
Glycotope Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh
Priority claimed from EP06090208.7A external-priority patent/EP1920781B1/en
Publication of RS53996B1 publication Critical patent/RS53996B1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RS20150240A 2006-11-10 2006-11-10 COMPOSITIONS CONTAINING CORE-1 POSITIVE MICRO-ORGANISM AND THEIR APPLICATION FOR TREATMENT OR TUMOR PROPHYLAXIS RS53996B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06090208.7A EP1920781B1 (en) 2006-11-10 2006-11-10 Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors

Publications (1)

Publication Number Publication Date
RS53996B1 true RS53996B1 (en) 2015-10-30

Family

ID=41421508

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20150240A RS53996B1 (en) 2006-11-10 2006-11-10 COMPOSITIONS CONTAINING CORE-1 POSITIVE MICRO-ORGANISM AND THEIR APPLICATION FOR TREATMENT OR TUMOR PROPHYLAXIS

Country Status (9)

Country Link
CN (1) CN101600454A (zh)
CY (1) CY1116319T1 (zh)
DK (1) DK1920781T3 (zh)
ES (1) ES2533965T3 (zh)
HR (1) HRP20150363T1 (zh)
PT (1) PT1920781E (zh)
RS (1) RS53996B1 (zh)
SI (1) SI1920781T1 (zh)
UA (1) UA103153C2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014004123A2 (pt) * 2011-08-22 2017-03-01 Glycotope Gmbh micro-organismos das espécies bacteroides xylanisolvens
US20150064220A1 (en) * 2012-03-27 2015-03-05 Abbott Laboratories Methods for modulating cell-mediated immunity using human milk oligosaccharides
CN103320363B (zh) * 2013-07-03 2015-02-18 广州中国科学院先进技术研究所 一种用于分离筛选乳酸菌的培养基、配制方法及应用
CN111323283B (zh) * 2020-04-20 2021-06-25 厦门大学 一种富集n-磷酸化蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789027B1 (en) * 2004-07-26 2013-09-04 The Research Foundation Of State University Of New York Therapeutic use of anti-tf-antigen antibody

Also Published As

Publication number Publication date
HRP20150363T1 (hr) 2015-07-31
UA103153C2 (ru) 2013-09-25
ES2533965T3 (es) 2015-04-16
DK1920781T3 (en) 2015-04-20
SI1920781T1 (sl) 2015-07-31
CY1116319T1 (el) 2017-02-08
PT1920781E (pt) 2015-05-18
CN101600454A (zh) 2009-12-09

Similar Documents

Publication Publication Date Title
RS51563B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ROOSUVASTATIN CALCIUM
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
UY30030A1 (es) Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones
BRPI0509074A (pt) composições farmacêuticas compreendendo agonistas do receptor da tiróide
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
AU2001278003A1 (en) Bacteriophage having multiple host range
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
MX2009013295A (es) Estuche y metodo para aplicaciones de tratamiento para el cabello.
PH12015500550A1 (en) Anti-notch1 nrr antibodies and methods using same
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
HUS1800013I1 (hu) Cladribine tartalmú orális gyógyászati készítmény
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
BRPI0809977A8 (pt) Uso de um composto, compostos e composição farmacêutica que o contém
IS2303B (is) Glýkópeptíð fosfónatafleiður
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
CL2004000965A1 (es) Compuestos derivados de 2h-pirazol-3-il de formula definida, que actuan como inhibidores de quinasa p38 y tnf; composicion farmaceutica que comprende a uno de los compuestos; uso de la composicion en la preparacion de un medicamento; y uso de los com
MY133335A (en) Photoresist compositions
SI1539114T1 (sl) Filmska obloga za tablete in kaplete
CR20220014A (es) Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos
JOP20220093A1 (ar) تركيبة صيدلانية تشتمل على سيليكسيباغ
RS53996B1 (en) COMPOSITIONS CONTAINING CORE-1 POSITIVE MICRO-ORGANISM AND THEIR APPLICATION FOR TREATMENT OR TUMOR PROPHYLAXIS
EP2125831A4 (en) ISOFLAVONOID OXAZINYL COMPOUNDS, MEDICAMENTS AND USE
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
SG134180A1 (en) Composition for treating or preventing hot flashes and use thereof
WO2009076243A3 (en) Novel uses of chloramphenicol and analogues thereof